Goldman Sachs Group Analysts Give Lanxess (LXS) a €57.00 Price Target

Goldman Sachs Group set a €57.00 ($66.28) target price on Lanxess (ETR:LXS) in a research note issued to investors on Tuesday morning. The brokerage currently has a buy rating on the stock.

Several other brokerages also recently commented on LXS. Jefferies Financial Group set a €61.00 ($70.93) target price on Lanxess and gave the stock a neutral rating in a research note on Tuesday, November 13th. Societe Generale set a €62.00 ($72.09) target price on Lanxess and gave the stock a neutral rating in a research note on Tuesday, November 13th. Credit Suisse Group set a €65.00 ($75.58) target price on Lanxess and gave the stock a neutral rating in a research note on Tuesday, November 13th. Independent Research set a €59.00 ($68.60) target price on Lanxess and gave the stock a neutral rating in a research note on Tuesday, November 13th. Finally, Warburg Research set a €79.00 ($91.86) price target on Lanxess and gave the stock a buy rating in a report on Tuesday, November 13th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of Hold and an average target price of €62.14 ($72.25).

Shares of ETR LXS opened at €48.33 ($56.20) on Tuesday. The company has a debt-to-equity ratio of 75.18, a current ratio of 2.54 and a quick ratio of 0.50. The stock has a market cap of $4.39 billion and a price-to-earnings ratio of 15.63. Lanxess has a 12 month low of €39.47 ($45.90) and a 12 month high of €72.60 ($84.42).

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Featured Story: How a Strangle Strategy is different from a Straddle Strategy

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply